Provided by Tiger Trade Technology Pte. Ltd.

Tectonic Therapeutic, Inc.

30.38
-0.8400-2.69%
Post-market: 30.380.00000.00%16:10 EDT
Volume:167.35K
Turnover:5.09M
Market Cap:593.91M
PE:-6.65
High:31.80
Open:31.22
Low:29.77
Close:31.22
52wk High:39.53
52wk Low:14.39
Shares:19.55M
Float Shares:12.20M
Volume Ratio:0.54
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5678
EPS(LYR):-4.0500
ROE:-33.80%
ROA:-22.29%
PB:2.65
PE(LYR):-7.50

Loading ...

Tectonic Therapeutic (TECX) Gets a Buy from Oppenheimer

TIPRANKS
·
Sep 01

Tectonic Therapeutic (TECX) Receives a Buy from Piper Sandler

TIPRANKS
·
Aug 31

Tectonic Therapeutic CSO Peter McNamara Disposes of USD 1,570.36 in Common Shares

Reuters
·
Aug 27

Tectonic Therapeutic CSO Peter McNamara Reports TECX Common Share Disposal Worth $1,505 on Aug. 12

Reuters
·
Aug 15

Truist Financial Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)

TIPRANKS
·
Aug 10

Piper Sandler Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)

TIPRANKS
·
Aug 07

Tectonic Therapeutic Q2 EPS $(1.18) Beats $(1.37) Estimate

Benzinga Earnings
·
Aug 07

Tectonic Therapeutic Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights

THOMSON REUTERS
·
Aug 07

Tectonic Therapeutic Inc Expected to Post a Loss of $1.35 a Share - Earnings Preview

Reuters
·
Aug 03

Tectonic Therapeutic CSO Peter Mcnamara Disposes of USD 6,020 in Common Shares

Reuters
·
Jul 02

Xeris Names CEO John Shannon Board Chair, Effective July 1, 2026

Reuters
·
Jun 30

Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX) and Stevanato Group (STVN)

TIPRANKS
·
Jun 11

Tectonic Therapeutic files Form 3 for director Jessica Caroline Chutter

Reuters
·
Jun 11

Tectonic Therapeutic completes enrollment in TX45 APEX Phase 2 trial for PH-HFpEF patients

Reuters
·
Jun 11

Tectonic Therapeutic - Tx45 Apex Phase 2 Topline Results Expected in Early Q1 2027

THOMSON REUTERS
·
Jun 11

Tectonic Therapeutic Completes Enrollment in Tx45 Apex Phase 2 Clinical Trial in Ph-Hfpef Patients

THOMSON REUTERS
·
Jun 11

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tectonic Therapeutic (TECX) and Urogen Pharma (URGN)

TIPRANKS
·
May 18

LifeSci Capital Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)

TIPRANKS
·
May 16

Oppenheimer Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)

TIPRANKS
·
May 15